Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9GZT4
UPID:
SRR_HUMAN
Alternative names:
D-serine ammonia-lyase; D-serine dehydratase; L-serine ammonia-lyase; L-serine dehydratase
Alternative UPACC:
Q9GZT4; D3DTI5; Q6IA55
Background:
Serine racemase, known by alternative names such as D-serine ammonia-lyase and L-serine dehydratase, plays a pivotal role in the synthesis of D-serine from L-serine. D-serine acts as a crucial coagonist alongside glutamate at NMDA receptors, highlighting its significance in neurotransmission. The enzyme also exhibits dehydratase activity towards both L-serine and D-serine, underscoring its versatility in amino acid metabolism.
Therapeutic significance:
Understanding the role of Serine racemase could open doors to potential therapeutic strategies. Its involvement in the synthesis of D-serine, a key neurotransmitter coagonist, positions it as a critical target for exploring treatments related to neurological disorders.